Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Conducting Filter Compatibility Studies – V 2.0

Posted on By

Analytical Method Development: SOP for Conducting Filter Compatibility Studies – V 2.0

Standard Operating Procedure for Conducting Filter Compatibility Studies in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/358/2025
Supersedes SOP/AMD/358/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

The purpose of this SOP is to define the standardized approach for conducting filter compatibility studies during analytical method development. This ensures that selected filters do not adsorb or retain active

pharmaceutical ingredients (API) or excipients, thus preserving the integrity of the analytical results.

2. Scope

This SOP applies to all filter compatibility assessments performed for analytical methods developed or validated within the Analytical Method Development (AMD) department for pharmaceutical formulations and API samples.

3. Responsibilities

  • Analytical Scientist: Responsible for planning and executing the filter compatibility study.
  • QA Reviewer: Ensures that the filter study design and outcomes meet compliance and documentation standards.
  • Section Head – AMD: Reviews and approves the filter compatibility study report.
See also  Analytical Method Development: Colorimetric Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development shall ensure that all filter compatibility studies are performed per this SOP and documented according to current regulatory expectations (e.g., FDA, ICH, WHO, CDSCO).

5. Procedure

5.1 Selection of Filters

  1. Identify filters based on chemical compatibility with diluent or sample matrix (e.g., Nylon, PVDF, PTFE, PES, RC).
  2. Select at least two different filter types and one unfiltered control for comparative analysis.
  3. Ensure filters have a pore size of 0.22 µm or 0.45 µm as appropriate to the method.

5.2 Preparation of Test Solutions

  1. Prepare standard solution of the target analyte in diluent as per method SOP.
  2. Divide into three aliquots:
    • One to be filtered through Filter A
    • One through Filter B
    • One unfiltered as control
  3. Filter the respective aliquots through the filters under identical conditions.

5.3 Chromatographic Evaluation

  1. Inject each aliquot in triplicate into the chromatographic system (e.g., HPLC).
  2. Compare the chromatograms for retention time, peak shape, area, and recovery percentage.
  3. Evaluate any changes in signal-to-noise ratio or baseline drift.
See also  Analytical Method Development: SOP for Documentation Practices During Method Development - V 2.0

5.4 Data Analysis and Interpretation

  1. Calculate the percentage recovery for Filter A and Filter B against the unfiltered control.
  2. Acceptable recovery range: 98%–102% of unfiltered sample.
  3. Document and justify the selected filter based on recovery, peak shape, and absence of interference.

5.5 Documentation

  1. Use Annexure-1: Filter Compatibility Worksheet to record results, chromatograms, and observations.
  2. Attach instrument printouts, integration data, and chromatographic conditions as part of the report.
  3. Ensure the study is reviewed and approved before finalizing method validation.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • PVDF: Polyvinylidene Difluoride
  • PTFE: Polytetrafluoroethylene
  • PES: Polyethersulfone
  • RC: Regenerated Cellulose
  • QA: Quality Assurance

7. Documents

  1. Annexure-1: Filter Compatibility Worksheet
  2. Annexure-2: Recovery Calculation Template
  3. Annexure-3: Filter Certificate of Analysis

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • FDA Guidance for Industry – Analytical Procedures and Methods Validation
  • USP General Chapter <1058> Analytical Instrument Qualification

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Manoj Kumar Deepa Ghosh Dr. A. N. Sharma
Designation Method Development Scientist QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Filter Compatibility Worksheet

Sample Filter Type Peak Area % Recovery Comment
Standard Unfiltered 10520 100% Control
Standard Filter A (PTFE) 10480 99.6% Accepted
Standard Filter B (Nylon) 10510 99.9% Accepted

Annexure-2: Recovery Calculation Template

% Recovery = (Peak Area of Filtered Sample / Peak Area of Unfiltered Sample) × 100

Annexure-3: Filter Certificate of Analysis

Attach manufacturer’s CoA for each filter used in the study including material compatibility, pore size, and batch number.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded scope and included annexure templates Annual SOP review Dr. A. N. Sharma
20/04/2022 1.0 Initial Release New SOP QA Head
See also  Analytical Method Development: Comparison of FTIR Spectra in AMD - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Documentation Practices in Chromatographic Data Handling – V 2.0
Next Post: Analytical Method Development: SOP for Preparing Calibration Curve Using External Standards – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version